Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease
- 1 December 1996
- journal article
- Published by Wiley in Journal of Applied Bacteriology
- Vol. 81, 72S-80S
- https://doi.org/10.1111/j.1365-2672.1996.tb04600.x
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- A controlled trial of six months chemotherapy in pulmonary tuberculosis: First report: Results during chemotherapyPublished by Elsevier ,2004
- The action of antituberculosis drugs in short-course chemotherapyPublished by Elsevier ,2004
- Early bactericidal activity as a method of assessment of drugs for the treatment of tuberculosisJournal of Antimicrobial Chemotherapy, 1994
- Understanding the chemotherapy of tuberculosis—current problemsJournal of Antimicrobial Chemotherapy, 1992
- Treatment of pulmonary tuberculosis with short course chemotherapy in South India—5-year follow upTubercle, 1989
- Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South IndiaTubercle, 1983
- Controlled clinical trial of four short-course regimens of chemotherapy for two durations in the treatment of pulmonary tuberculosis Second reportTubercle, 1980
- Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: The results up to 24 monthsTubercle, 1979
- CONTROLLED CLINICAL TRIAL OF FOUR SHORT-COURSE (6-MONTH) REGIMENS OF CHEMOTHERAPY FOR TREATMENT OF PULMONARY TUBERCULOSIS Second ReportThe Lancet, 1973
- Isoniazid with thiacetazone (Thioacetazone) in the treatment of pulmonary tuberculosis in East Africa—third investigation: The effect of an initial streptomycin supplement: A co-operative study in East African hospitals and laboratories with the collaboration of the East African and British medical research councilsTubercle, 1966